Hyon K Choi
NIH Rank #4141
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8095993Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$2.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#4,141
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Hyon K Choi as a PI. Multi-PI records show the full award amount for context.
- 5U01AR080985-03U01Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)$1.8Maward amount
- 5R01AR065944-09R01NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT$639.2Kaward amount
- 1R61AR084188-01A1R61SGLT2i As Novel Gout Care (SAVE-Care): A Randomized Controlled Trial$228.2Kaward amount
Award organization
Organizations that administered FY2025 awards listing Hyon K Choi as a PI.
FY2025 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3262
- 2024Entered Top 25% NationallyRanked #3262
- 2024R01 Grant Holder
- 2025$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Hyon K Choi.